Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | ARTV | CABA | ||
| Company | Urovant Sciences Ltd | Artiva Biotherapeutics Inc | Cabaletta Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 11.78 | 3.36 | ||
| High | 16.24 | 11.80 | 3.38 | ||
| Low | 16.21 | 11.00 | 3.11 | ||
| Last | 16.24 | 11.09 | 3.12 | ||
| Change | +0.01 | -0.85 | -0.26 | ||
| Percent Change | +0.06% | -7.12% | -7.69% | ||
| Volume | 1,739,000 | 223,400 | 3,239,300 | ||
| 20-Day Average Volume | 143,510 | 315,050 | 4,345,165 | ||
| Previous | 16.23 | 11.94 | 3.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 11.44 | 2.95 | ||
| 20-Day Raw Stochastic | 87.10% | 50.21% | 61.99% | ||
| 20-Day Relative Strength | 65.56 | 52.54 | 54.39 | ||
| Weighted Alpha | +6.45 | +16.09 | +28.00 | ||
| Today's Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 96% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +1.46% since 08/21/26 | -0.32% since 08/21/26 | ||
| Low | 16.20 on 03/24/21 | 10.49 on 08/24/26 | 3.01 on 08/24/26 | ||
| High | 16.25 on 03/25/21 | 12.08 on 08/27/26 | 3.44 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +5.32% since 07/28/26 | +14.29% since 07/28/26 | ||
| Low | 16.10 on 03/02/21 | 9.67 on 07/31/26 | 2.59 on 08/03/26 | ||
| High | 16.26 on 03/19/21 | 12.27 on 08/11/26 | 3.44 on 08/27/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +45.73% since 05/28/26 | -17.24% since 05/28/26 | ||
| Low | 16.03 on 12/30/20 | 6.59 on 06/02/26 | 2.59 on 08/03/26 | ||
| High | 16.26 on 03/19/21 | 12.27 on 08/11/26 | 3.93 on 06/03/26 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +90.55% since 02/27/26 | -6.02% since 02/27/26 | ||
| Low | 7.15 on 11/02/20 | 4.74 on 03/27/26 | 2.45 on 03/30/26 | ||
| High | 16.26 on 03/19/21 | 14.53 on 04/20/26 | 4.23 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 542,190 | 528,980 | ||
| Shares Outstanding, K | 32,743 | 48,890 | 169,545 | ||
| Annual Sales, $M | 0 | 0 | 0 | ||
| Annual Net Income, $M | -146,750,000 | -83,870,000 | -167,860,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 0 | ||
| Last Qtr Income, $M | -46,800,000 | -25,010,000 | -51,020,000 | ||
| 60-Month Beta | 2.35 | 2.16 | 3.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.63 on 08/06/26 | -0.34 on 08/13/26 | ||
| Latest Earnings Date | 06/17/21 | 11/11/26 | 11/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||